STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Aditxt, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Aditxt, Inc. (ADTX) reported an insider transaction by its Chief M&A Officer on a Form 4. On 11/25/2025, the officer sold 1 share of Aditxt common stock at a price of $3.2 per share in a transaction coded "S" for sale. After this small tax-related sale, the reporting person held 0 shares of Aditxt common stock directly. The explanation notes that the share was sold for tax-related purposes.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pankovcin Corinne

(Last) (First) (Middle)
2569 WYANDOTTE STREET, SUITE 101

(Street)
MOUNTAIN VIEW CA 94043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Aditxt, Inc. [ ADTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief M&A Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/25/2025 S(1) 1 D $3.2 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The share was sold by the Reporting Person for tax related purposes.
/s/Corinne Pankovcin 11/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aditxt (ADTX) disclose in this Form 4?

The Chief M&A Officer of Aditxt, Inc. reported selling 1 share of Aditxt common stock on 11/25/2025 in a transaction coded as a sale.

At what price was the Aditxt (ADTX) share sold by the officer?

The reporting officer sold 1 share of Aditxt common stock at a price of $3.2 per share.

How many Aditxt (ADTX) shares does the reporting person own after this transaction?

Following the reported transaction, the Chief M&A Officer beneficially owns 0 shares of Aditxt common stock directly.

What is the stated reason for the Aditxt insider share sale?

The explanation states that the share was sold for tax-related purposes by the reporting person.

What is the role of the reporting person at Aditxt (ADTX)?

The reporting person is identified as an Officer of Aditxt, specifically holding the title Chief M&A Officer.

Is this Aditxt (ADTX) Form 4 filed by one or multiple reporting persons?

The filing indicates that it is a Form filed by one reporting person, not a joint filing.

Aditxt Inc

NASDAQ:ADTX

ADTX Rankings

ADTX Latest News

ADTX Latest SEC Filings

ADTX Stock Data

1.47M
559.44k
0.79%
2.64%
Biotechnology
Pharmaceutical Preparations
Link
United States
RICHMOND